Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Fintech lender Plenti sees its loan portfolio grow to $1.67 billion, sells off bad debts
    • News

    Fintech lender Plenti sees its loan portfolio grow to $1.67 billion, sells off bad debts

    The Australian housing market has left people in limbo with mortgage pressures forcing them to pinch pennies. As they cast around for low-cost lenders, fintech loan providers like Plenti (ASX: PLT) are enjoying their time in the spotlight.  In Q2 FY23, Plenti’s loan portfolio increased to $1.67 billion, 51% above Q2 FY22 and 8% above

    Read More
    Public
  • JB Hi-Fi sales propel to $5.3 billion as customers return to in-store shopping
    • News

    JB Hi-Fi sales propel to $5.3 billion as customers return to in-store shopping

    It was the quarter to be in retail as Boxing Day and Christmas sales ushered in significant sales and the eradication of Covid lockdowns enabling Aussies to return to in-store shopping.  Putting Covid on the back burner, 2023 looks pretty for retail businesses eagerly awaiting this return. Plus, with household budgets squeezed due to rising

    Read More
    Public
  • The Market Herald appoints Gumtree boss Tommy Logtenberg as Interim CEO
    • News

    The Market Herald appoints Gumtree boss Tommy Logtenberg as Interim CEO

    Following the unfolding of the Jag Sanger drama, media house and classified ads agency The Market Herald (ASX: TMH) is attempting to move on from the awkwardness with the appointment of new Interim CEO Tommy Logtenberg. Logtenberg is also the CEO and CFO of classified ads company Gumtree, which was acquired by The Market Herald

    Read More
    Public
  • Oliver’s reports $2.6 million in sales as Aussies shift to healthier eating habits
    • News

    Oliver’s reports $2.6 million in sales as Aussies shift to healthier eating habits

    Aussies have entered the new year on a healthy note as nutritional quick-service eatery Oliver’s Real Food (ASX: OLI) reported sales of $2.6 million in December 2022.  Its unaudited earnings for December were $231k on sales of $2.6 million with the Oliver’s responding to the ASX’s regulatory requirements asking the Company to report monthly cash

    Read More
    Public
  • Little Green Pharma’s roll of fortune – looking ahead to growing European Pipeline
    • News

    Little Green Pharma’s roll of fortune – looking ahead to growing European Pipeline

    Little Green Pharma (ASX: LGP) has been on a roll this quarter. Increasing cash receipts by 35% from $4.4 million to $6 million, the Company has made strides in its cannabis operations. The influx of revenue was thanks to the first shipment of new strains from Denmark, which earned more than $0.5 million over five

    Read More
    Public
  • Aerometrex bags $2 million Australian Government contract for its LiDAR tech
    • News

    Aerometrex bags $2 million Australian Government contract for its LiDAR tech

    When was the last time you used Google or Apple maps? Perhaps just yesterday as you cast around for that eatery or maybe even on your way to work. With Google maps, you can zoom in and out of areas, discover precise locations and even get recommendations on how to get to your destination through

    Read More
    Public
  • «
  • ‹
  • 292
  • 293
  • 294
  • 295
  • 296
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.